JNJ · NYSE
Johnson & Johnson stock trading platform: trade the JNJ stock as a CFD
To trade the Johnson & Johnson (JNJ) stock, open an account with a provider licensed by the FSCA, deposit funds, then place your buy or sell order on the stock CFD from MetaTrader 5. JNJ is one of the 30 components of the Dow Jones, the benchmark index for US index trading. The company is listed on the New York stock exchange, in dollars (USD). This page gives you the dated figures, the method and the risks, before your first order.
The essentials as of 13 October 2026. Johnson & Johnson pays a quarterly dividend of $1.34 per share, i.e. $5.36 per year, after 64 consecutive years of increases (press release of 14 April 2026, filed with the SEC). Its Q3 2026 results were published on 13 October 2026. Unless otherwise stated, the data presented on this page are dated 29 and 30 September 2026.
This table brings together the key figures of Johnson & Johnson, recorded on 30 September 2026 and updated on 13 October 2026. Each line cites its date and source. No value is estimated by us.
| Indicator | Value | Date | Source |
|---|---|---|---|
| Q2 2026 sales | $25.31 billion | 15 July 2026 | Johnson & Johnson press release (SEC) |
| Adjusted EPS for Q2 2026 | $2.90 | 15 July 2026 | Johnson & Johnson press release (SEC) |
| 2026 sales guidance | $101.0 to $101.4 billion | 13 October 2026 | Form 8-K (SEC) |
| 2026 adjusted EPS guidance | $11.05 to $11.15 | 13 October 2026 | Form 8-K (SEC) |
| Quarterly dividend | $1.34, i.e. $5.36 per year | 14 April 2026 | Form 8-K (SEC) |
| Last dividend paid | $1.34 on 8 September 2026 | 15 July 2026 | Johnson & Johnson press release |
| Dividend yield | 1.98% | 30 September 2026 | Analyst |
| 52-week range | $179.80 to $281.07 | 30 September 2026 | Analyst |
| Market capitalization | Approximately $655 billion | 30 September 2026 | Analyst |
| Latest results | Q3 2026, published on 13 October 2026 | 13 October 2026 | Form 8-K (SEC) |
Johnson & Johnson stock price: where to read the live price
The price of the Johnson & Johnson stock is formed in dollars (USD) on the New York Stock Exchange, where the security is listed under the symbol JNJ. It is displayed live during Wall Street opening hours, from 15:30 to 22:00, Paris time.
The price changes every second. We therefore do not freeze it on this page. We give you dated reference points: a 52-week range of $179.80 to $281.07 and a market capitalization of approximately $655 billion (often called "market cap"), recorded on 30 September 2026.
- The change on the day, in value and in percentage, indicates the direction of the market.
- The 1-year and 5-year chart places the current price within its history.
- The traded volume confirms, or not, a rise or a fall.
On pages titled "Johnson & Johnson stock prices", always check the listing venue. Some sites display "Johnson & Johnson DRC", another quote line, located in Canada. It is not the NYSE stock. Its price may be very different. Keep an overview before comparing two prices.
How to open your account and trade the Johnson & Johnson stock in 3 steps?
The process follows the usual account creation steps.
1. Register: create your RaiseFX account
Fill in the online registration form. A few basic details are enough to generate your login credentials for the client area. Read the legal documents before confirming.
2. Verify: verify your personal profile
Submit a recent proof of identity and proof of address, according to KYC rules. Your personal data is processed in accordance with RaiseFX's privacy policy. This legal obligation also applies to your future withdrawals.
3. Start trading: place your orders on JNJ
Deposit funds by card, bank transfer or crypto. The available methods are detailed on the deposits and withdrawals page. Then open the MetaTrader 5 trading platform and search for Johnson & Johnson (JNJ) in the list of instruments. MetaTrader 5 is also available as a mobile app. Analyze the chart, then send your order.
Before your first trade, check the spreads and commissions and the margin conditions.
CFD or direct stock: what changes with Johnson & Johnson
A CFD, or contract for difference, is a derivative product that may involve leverage. You do not become the owner of the stock. You bet on the price difference between the opening and the closing of your position.
A long position corresponds to a purchase and a short position to a sale. You also adjust the size of your contracts in lots and micro-lots to adapt your exposure to your capital.
| Criterion | Johnson & Johnson JNJ CFD | Direct Johnson & Johnson JNJ stock | Healthcare ETF |
|---|---|---|---|
| Ownership of the stock | No, derivative contract | Yes | No, units of a fund |
| Direction of the position | Rise or fall | Generally a rise | Generally a rise |
| Leverage | Yes, it amplifies gains and losses | No, except with credit | No, except with credit |
| Dividend | Adjustment generally on the ex-dividend date | Paid to the shareholder | Depends on the fund |
| Voting right | No | Yes | No |
| PEA and life insurance | Not eligible | US stock not eligible for the PEA | Depends on the ETF |
To buy Johnson & Johnson shares and hold them, you must go through a broker, or brokerage firm, for direct stocks. The settlement of a CFD is made in cash, without delivery of securities. It can be used in different strategies. It cannot be held in a PEA or in a life insurance contract.
Johnson & Johnson dividends: amount, schedule and yield
Johnson & Johnson announced a quarterly dividend of $1.34 per share on 14 April 2026. It is the 64th consecutive year of increase. The indicated annual dividend thus goes from $5.20 to $5.36.
The Q3 dividend, of $1.34 per share, was paid on 8 September 2026. It went to shareholders on record on 25 August 2026, the ex-dividend date. Based on $5.36 per year, the yield comes out at 1.98% according to market data.
| Announcement | Quarterly dividend | Change | Indicated annual dividend |
|---|---|---|---|
| 18 April 2023 | $1.19 | — | $4.76 |
| April 2024 | $1.24 | Level recalled in the April 2025 press release | $4.96 |
| 15 April 2025 | $1.30 | — | $5.20 |
| 14 April 2026 | $1.34 | — | $5.36 |
On a CFD, the dividend is not paid as it is to a shareholder. It generally takes the form of an adjustment to your account on the ex-dividend date. Check this rule in the contract conditions before opening a short position just before that date.
Quarterly results: the schedule to follow
The schedule matters as much as the chart. Johnson & Johnson published its Q3 2026 results on 13 October 2026: sales of $25.4 billion, up 5.9% year on year, and adjusted EPS of $2.59.
In Q2, sales reached $25.31 billion. Adjusted earnings per share came to $2.90. Net income reached $5.534 billion. On 13 October 2026, the group raised its 2026 estimates: sales of $101.0 to $101.4 billion, adjusted EPS of $11.05 to $11.15.
The results published by the company include data on EPS and research and development expenses.
- Published sales and their comparison with previous data.
- EPS, checking whether it is reported or adjusted: the two bases give different figures.
- The annual data communicated by the company.
- Product news, such as the Caplyta phase III trial program in bipolar mania.
Results days carry risks. Before a release, consult the available data and the calendar. The price can move sharply within a few minutes. An order may then be executed at a price different from the one requested: this is slippage. Take it into account in your risk management.
Reading the published financial data
Published estimates do not guarantee a future price and do not constitute a recommendation.
Consult the dated market data and bear in mind that the price may vary.
How to analyze the Johnson & Johnson stock: a 4-step method
A good analysis combines several readings. None is enough on its own.
1. Fundamental analysis. Look at sales, EPS, the net margin of 21.86% in Q2, the dividend and the 12-month P/E of 31.44 (Analyst 30 September 2026).
2. Technical analysis. Study the trend, supports, resistances and every useful indicator: moving averages, RSI, volumes.
3. Calendar. Note the results, the ex-dividend date, court rulings and FDA approvals, such as that of the THERMOCOOL SMARTTOUCH SF system.
4. Risk management. Set the position size and the stop level before the order.
A stock screener helps compare Johnson & Johnson with its healthcare sector peers. Among the Dow Jones components, Merck, Amgen Inc. and UnitedHealth are common points of comparison.
In 2023, the group described itself as a worldwide healthcare products company. The Dow Jones is price-weighted, unlike the CAC 40, which is weighted by capitalization. JNJ therefore weighs according to its price, not its size.
JNJ's beta is 0.23 over 5 years, according to Analyst 30 September 2026. The stock has therefore been little sensitive to movements of the broad index. This does not protect against a decline linked to news specific to the company.
MetaTrader 5 provides the useful tools: charts, technical indicators and price alerts. Combine them with the fundamental information in the table on this page. Your choice of indicator matters less than your discipline.
What are the risks of investing in JNJ?
CFD trading carries a high level of risk. It may not be suitable for all investors. Here are the risks specific to JNJ.
- Legal risk. Court rulings related to talc remain ongoing, according to a source published in July 2026.
- Valuation risk. The published P/E is 31.44.
- Earnings risk. The research and development expense is $0.64 per share in 2026.
- Event risk. A price gap may appear between the close and the open of Wall Street, around releases.
- Margin risk. A position may be closed if the margin becomes insufficient.
- Currency risk. The price is in USD. If your account is in EUR or in another currency, the EUR/USD rate affects your performance.
Define your capital at risk before the order. A loss may exceed what you had planned. The information on this page is provided for general and educational information. None of it constitutes investment advice. This page promises no gain and is not an advertisement for a guaranteed return.
Which criteria should you check before trading Johnson & Johnson as a CFD?
Platforms can be assessed against verifiable criteria.
| Criterion | What to check | What RaiseFX states |
|---|---|---|
| Regulation | The authority and the license number | Financial Sector Conduct Authority (FSCA), FSP 50506 |
| Security of funds | Segregation of accounts | Information on the handling of client funds in the legal documents |
| Costs | Spreads, commissions, financing | Page dedicated to spreads and commissions |
| Tools | Charts, indicators, alerts | MetaTrader 5 |
| Leverage | Margin level and rules | Margin conditions to check |
| Deposits | Withdrawal methods and times | Cards, bank transfers and cryptocurrencies |
| Support | Channels and language | Email support, Telegram and WhatsApp communities |
| Service area | Accepted countries | Site not intended for residents of the European Union |
Consult the trading conditions and check the fees as well as customer service. Also join the members' community on Telegram to ask your questions in French. RaiseFX is present on a professional social network, LinkedIn, and on Instagram.
Personal data and legal framework of RaiseFX
RaiseFX is operated by Raise Global SA (Pty) LTD, a financial services provider licensed by the Financial Sector Conduct Authority of South Africa, under licence FSP 50506.
The privacy policy explains how RaiseFX collects and uses your personal data. It relies on the South African law POPIA. Consult it to find out who the data controller is and about information requests from the persons concerned.
The information on the site is not intended for residents of the United States, Singapore or Australia, among others. The services are reserved for persons aged 18 or over. This restriction matters for your right of access to the service.
The figures on this page come from dated public sources: press releases filed with the SEC and financial news sites. The editorial team does not accept liability for these publishers. Their data remains subject to their copyright. RaiseFX also disclaims any liability for a loss related to the use of this information.
FAQ: everything you need to know about trading the Johnson & Johnson stock
Open an account, verify your identity, deposit funds, then place an order on the JNJ CFD. With a CFD, you do not hold the stock: the contract tracks its price. Holding the stock goes through a spot transaction. The US stock is not eligible for the PEA.
Nobody knows it. As of 29 September 2026, MarketBeat displays an average target of $274.13 and Barchart of $281.08. Individual targets range from $190 to $320 according to Yahoo Finance. Read these figures as scenarios, not as a promise.
The quarterly dividend is $1.34 per share, i.e. $5.36 per year, for a yield of 1.98%. The last payment dates from 8 September 2026. The group raised its dividend for the 64th consecutive year in April 2026.
None is recommended for all profiles. Check the regulation, the information on client funds, the costs, the tools and the service area. RaiseFX indicates an FSCA licence (FSP 50506) and MetaTrader 5.
Combine three readings: fundamental (sales, EPS, dividend, valuation), technical (trend, supports, indicators) and calendar (quarterly results, ex-dividend date). Set a risk rule before opening the position.
The main ones are talc-related litigation, a high valuation (P/E of 31.44), a research expense of $0.64 per share in 2026, movements around results and, with CFDs, leverage and currency risk.
Take a position on Johnson & Johnson stock with RaiseFX
Information on the trading conditions. RaiseFX gives you an infrastructure and a regulatory framework supervised by the FSCA.